Buyer landscape
Likely buyers · Biotech in Austria.
Prepared 2026-08-28 with GP Intel · deterministic scoring, published weights: gp-intel.com/methodology/league-tables
The list: 25 Tier 1 · 0 Tier 2 of 120 matched buyers, including 15 geographic expansion candidates without a local platform yet. A first round of the Tier 1 names plus the expansion buyers covers the demonstrated demand.
Financial buyers · 24
Tier 1 · Very High · score 70+
2. NORD Holding SponsorVery High81
15 platform investments in Healthcare · 1 in Austria · 15 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 13 deals in the last 2 years vs 2.5/yr before.
Bought Hallmarq Veterinary Imaging from August Equity, 2026 · MedTech, UK
3. Bpifrance Investissement SponsorVery High80
10 platform investments in Healthcare · 35 deals 2024–26
AUM €57.3B · Bpifrance Amorçage Industriel · 2023 vintage · deploying · check €1-8M
Accelerating: 30 deals in the last 2 years vs 4.5/yr before.
Backed Adcendo, 2026 · Biotech, Denmark
4. Archimedes Partners SponsorVery High80
53 platform investments in Healthcare · 1 in Austria · 21 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
5. Novo Holdings SponsorVery High79
114 platform investments in Healthcare · 1 in Austria · 43 deals 2024–26
AUM €93.0B · Novo Holdings Bioindustrial Investments · 1999 vintage · no newer fund
142 platform investments since the 1999 vintage · largely deployed vs its usual 24 per fund.
Backed cAMPfield, 2026 · Biotech, US
6. ArchiMed SponsorVery High79
56 platform investments in Healthcare · 1 in Austria · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
7. ARCHIMED and Institut Mérieux SponsorVery High79
54 platform investments in Healthcare · 1 in Austria · 19 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
8. ArchiMed and Tethys Invest SponsorVery High79
54 platform investments in Healthcare · 1 in Austria · 18 deals 2024–26
AUM €9.0B · MED Rise · 2024 vintage · deploying · check €8-60M
18 platform investments since the 2024 vintage · largely deployed vs its usual 9 per fund.
Backed ExcellGene, 2025 · Biotech, Switzerland
9. NORD Holding / Pinova Capital SponsorVery High79
12 platform investments in Healthcare · 1 in Austria · 12 deals 2024–26
AUM €5.0B · NORD Holding all inclusive Fitness Continuation Fund · 2026 vintage · deploying
Accelerating: 10 deals in the last 2 years vs 2.5/yr before.
Backed Hallmarq Veterinary Imaging, 2026 · MedTech, UK
10. Armira SponsorVery High79
6 platform investments in Healthcare · 2 in Austria · 12 deals 2024–26
AUM €5.0B · Armira III · 2025 vintage · deploying · check €20-150M
8 platform investments since the 2025 vintage · mid-deployment vs its usual 10 per fund.
Backed nyra health, 2026 · HealthTech, Austria
11. Inflexion SponsorVery High78
10 platform investments in Healthcare · 27 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
4 platform investments since the 2026 vintage · mid-deployment vs its usual 6 per fund.
Bought Primed from Paragon Partners, 2026 · MedTech, Germany
12. Merieux Equity Partners / Vitruvian Partners SponsorVery High78
57 platform investments in Healthcare · 6 deals 2024–26
AUM €1.6B · Mérieux Participations 5 · 2026 vintage · deploying · check €7-50M
2 platform investments since the 2026 vintage · early in deployment vs its usual 8 per fund.
Backed Ona Therapeutics, 2026 · Biotech, Spain
13. bm-t Beteiligungsmanagement Thueringen SponsorVery High78
13 platform investments in Healthcare · 13 deals 2024–26
AUM €465M · Mittelstands-Fonds Thueringen II (MFT II) · 2025 vintage · deploying · check €0-3M
Accelerating: 8 deals in the last 2 years vs 2.5/yr before.
Backed Applyo Jena, 2025 · Biotech, Germany
14. Lauxera Capital Partners SponsorVery High77
16 platform investments in Healthcare · 6 deals 2024–26
AUM €780M · Lauxera Growth II · 2025 vintage · deploying · check €10-78M
3 platform investments since the 2025 vintage · early in deployment vs its usual 8 per fund.
Backed GenePlanet, 2026 · Biotech, Slovenia
15. IK Partners SponsorVery High76
34 platform investments in Healthcare · 1 in Austria · 52 deals 2024–26
AUM €13.8B · IK Partnership Fund III · 2025 vintage · deploying · check €10-75M
18 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Bought Biobank from Bpifrance Investissement, 2024 · Biotech, France
16. Audacia SponsorVery High76
9 platform investments in Healthcare · 27 deals 2024–26
AUM €2.8B · Audacia Capital Développement IV · 2023 vintage · deploying · check €4-30M
45 platform investments since the 2023 vintage · largely deployed vs its usual 12 per fund.
Backed Biomemory, 2025 · Biotech, France
17. GHO Capital Partners SponsorVery High76
21 platform investments in Healthcare · 4 deals 2024–26
AUM €9.0B · GHO Capital IV LP · 2025 vintage · deploying · check €50-375M
3 platform investments since the 2025 vintage · mid-deployment vs its usual 6 per fund.
Backed Avid Bioservices, 2025 · Biotech, US
18. Ring Capital SponsorVery High75
10 platform investments in Healthcare · 32 deals 2024–26
AUM €470M · Ring Altitude II · 2025 vintage · deploying · check €4-33M
17 platform investments since the 2025 vintage · largely deployed vs its usual 13 per fund.
Backed Exapto, 2024 · Biotech, France
19. Inflexion (Partnership Capital III) SponsorVery High75
9 platform investments in Healthcare · 25 deals 2024–26
AUM €11.0B · Inflexion Buyout Fund VII · 2026 vintage · deploying · check €90-675M
Accelerating: 15 deals in the last 2 years vs 5.0/yr before.
Backed Primed, 2026 · MedTech, Germany
20. Bridgepoint SponsorVery High74
34 platform investments in Healthcare · 2 in Austria · 43 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Bought {my}dentist (formerly IDH) from Palamon Capital Partners, 2025 · Healthcare, UK
21. Bridgepoint Development Capital SponsorVery High74
31 platform investments in Healthcare · 1 in Austria · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
22. Bridgepoint (52.5% majority stake) SponsorVery High74
30 platform investments in Healthcare · 1 in Austria · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
23. Bridgepoint BE VII + General Atlantic SponsorVery High74
30 platform investments in Healthcare · 1 in Austria · 37 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
24. Bridgepoint Capital SponsorVery High74
31 platform investments in Healthcare · 1 in Austria · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
25. Bridgepoint Capital Developpement SponsorVery High74
30 platform investments in Healthcare · 1 in Austria · 36 deals 2024–26
AUM €86.6B · Europe VIII (BE VIII) · 2026 vintage · deploying · check €120-900M
4 platform investments since the 2026 vintage · early in deployment vs its usual 20 per fund.
Backed {my}dentist (formerly IDH), 2025 · Healthcare, UK
Strategic buyers · 1
Tier 1 · Very High · score 70+
1. Gilead Sciences CorporateVery High82
6 acquisitions in Healthcare · 4 deals 2024–26
Accelerating: 4 deals in the last 2 years vs 0.3/yr before.
Bought Tubulis from Athos, 2026 · Biotech, Germany
Scores and facts derive from verified deal records only; sample floors and thresholds are published on the methodology page. Figures marked with a tilde are bands, not disclosures.